1- Aarons, D. H., G. Victor Rossi and R. F. Orzechowski. 1977. Cardiovascular Actions of Three Harmala Alkaloids: Harmine, Harmaline, and Harmalol. Journal of Pharmaceutical Sciences 66: 1244-1248.
2- Alenajaf, A., E. Mohebi, A. Moghimi, M. Fereidoni and M. Mohammad-Zadeh. 2019. The effect of harmaline on seizures induced by amygdala kindling in rats. Neurological Research 41: 528-535.
3- Aricioglu, F. and H. Altunbas. 2003. Harmane Induces Anxiolysis and Antidepressant‐Like Effects in Rats. Annals of the New York Academy of Sciences 1009: 196-201.
4- Biradar, S., H. Joshi and K. Tarak. 2013. Cerebroprotective effect of isolated harmine alkaloids extracts of seeds of Peganum harmala L. on sodium nitrite-induced hypoxia and ethanol-induced neurodegeneration in young mice. Pakistan Journal of Biological Sciences: PJBS 16: 1687-1697.
5- Ebrahimi-Ghiri, M., M. Nasehi and M.-R. Zarrindast. 2019. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. Behavioural Brain Research 364: 296-302.
6- Gholamhasan, V., S. Oryan, M. Fereidoni, L. Etemadi and F. Manafi. 2007. Effect of inhalation alcoholic extract of Peganum harmala on induction of anxiety like behavior in elevated plus-maze. Physiology and Pharmacology 11: 153-159.
7- Heshmati, P., M. Nasehi and M. R. Zarrindast. 2014. An overview of cognitive aspects of β-carbolines. Archives of Advances in Biosciences 5.
8- Hilber, P. and P. Chapillon. 2005. Effects of harmaline on anxiety-related behavior in mice. Physiology & behavior 86: 164-167.
9- Huang, R.-Q., C. L. Bell-Horner, M. I. Dibas, D. F. Covey, J. A. Drewe and G. H. Dillon. 2001. Pentylenetetrazole-induced inhibition of recombinant γ-aminobutyric acid type A (GABAA) receptors: mechanism and site of action. Journal of Pharmacology and Experimental Therapeutics 298: 986-995.
10- Katzung, B. G. 2001. Basic and Clinical Pharmacology. McGraw Hill press.
11- Liberzon, I., K. L. Phan, S. Khan and J. L. Abelson. 2003. Role of the GABAA receptor in anxiety: evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies. Current Neuropharmacology 1: 267-283.
12- Monsef, H. R., A. Ghobadi, M. Iranshahi and M. Abdollahi. 2004. Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. J Pharm Pharm Sci 7: 65-69.
13- Mycek , M. J., R. A. Havey and P. C. Champe. 2000. Lippincott's illustrated review pharmacology. Philadelphia.
14- Pellow, S., P. Chopin, S. E. File and M. Briley. 1985. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of neuroscience methods 14: 149-167.
15- Samsam Shariat , H. and M. F. 1991. Natural plant and drugs. Amirkabir pub(in persian). Tehran.
16- Sanger, D. J. 2004. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS drugs 18: 9-15.
17- Schlede, E., U. Mischke, R. Roll and D. Kayser. 1992. A national validation study of the acute-toxic-class method—An alternative to the LD 50 test. Archives of toxicology 66: 455-470.